Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Baylor College of Medicine
Research
First-in-class drug halts breast and ovarian cancer in mice
The small molecule, which indirectly targets the tough-to-drug MYC gene, worked even better when combined with PARP 1/2 inhibitor talazoparib.
Helen Floersh
Oct 27, 2023 7:45am
Human Breast Cell Atlas maps all cells in healthy breast tissue
Jul 7, 2023 12:37pm
Researchers set sights on probiotic for dry eye disease
Jun 20, 2023 11:00am
Molecule suppresses appetite in obese mice after exercise
Jun 15, 2022 11:01am
'What it takes': Genentech has 'never wavered' on Alzheimer's
Dec 1, 2021 7:00am
Immunai adds $215M to bank to help discovery drug targets
Oct 27, 2021 12:00pm